US equities
|
NVDA
$239.37
▲+0.20%
MU
$1,047.40
▼-1.56%
SPCX
$173.13
▲+1.20%
MRVL
$286.19
▲+5.51%
AMD
$650.31
▲+2.94%
INTC
$113.33
▼-2.46%
SNDK
$1,660.25
▼-2.58%
AVGO
$377.57
▲+4.16%
NVDA
$239.37
▲+0.20%
MU
$1,047.40
▼-1.56%
SPCX
$173.13
▲+1.20%
MRVL
$286.19
▲+5.51%
AMD
$650.31
▲+2.94%
INTC
$113.33
▼-2.46%
SNDK
$1,660.25
▼-2.58%
AVGO
$377.57
▲+4.16%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Orhub Inc
(OP:
ORHB
)
0.0002
UNCHANGED
Delayed Quote
Updated: 1:20 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Orhub Inc
< Previous
1
2
3
Next >
ORHub Acquires PUR Biologics, Entering the Global Medical Device Market
April 25, 2022
"PUR's technologies will bring new solutions for pain elimination and osteoarthritis." IRVINE, CA / ACCESSWIRE / April 25, 2022 / ORHub, Inc. (OTC PINK:ORHB) announced today it has purchased 100% of...
From
ORHUB, Inc.
Via
AccessWire
Topics
Intellectual Property
ORHub Prepares To Finalize Acquisition Of Pur Biologics
April 15, 2022
"ORHub plans to use PUR's patented technologies to treat osteoarthritis & joint cartilage" IRVINE, CA / ACCESSWIRE / April 15, 2022 / ORHub, Inc. (OTC Pink:ORHB) announced today it has reached a...
From
ORHUB, Inc.
Via
AccessWire
ORHub, Inc. the Courts Rule To "Dismiss With Prejudice" the Lawsuit Brought by Frederic J. Buonincontri & Axt Analytics, LLC
April 05, 2022
IRVINE, CA / ACCESSWIRE / April 5, 2022 / ORHub, Inc. (OTC PINK:ORHB) ORHub announced today it has received the court ruling of an "ORDER DISMISSING WITH PREJUDICE" the litigation brought by Frederic...
From
ORHub, Inc.
Via
AccessWire
Topics
Lawsuit
Orhub's Story Proves the Power of a Winning Culture
March 14, 2022
IRVINE, CA / ACCESSWIRE / March 14, 2022 / An Important message from the Chairman & CEO Dear Shareholders, It is an exciting time for ORHub. Our vision for the Company began in the operating room where...
From
ORHUB, Inc.
Via
AccessWire
ORHub Executes Letter Of Intent For Acquisition
March 07, 2022
"ORHub continues to evaluate synergistic opportunities which add revenue and broaden market opportunity." IRVINE, CA / ACCESSWIRE / March 7, 2022 / ORHub, Inc. (OTC PINK:ORHB). ORHub today announced it...
From
ORHUB, Inc.
Via
AccessWire
ORhub Announces Sean McMenamin as An Independent Member of The Board
December 06, 2021
IRVINE, CA / ACCESSWIRE / December 6, 2021 / ORHub, Inc. (OTC PINK:ORHB) ORHub today announces Sean McMenamin's addition to the Board of Directors. Mr. McMenamin will help to provide board level...
From
ORHUB, Inc.
Via
AccessWire
Topics
Artificial Intelligence
ORHUB Enters The Holidays, Generating Revenue Through Continued Customer Agreement
December 01, 2021
Six-figure revenue event & customer requests for FutureOR TM , demonstrate ORHub's effort to "Transform the Business of Surgery TM " is on target. IRVINE, CA / ACCESSWIRE / December 1, 2021 / ORHub,...
From
ORHUB, Inc.
Via
AccessWire
Topics
Artificial Intelligence
ORHub Prepares for New Platform Launch
November 29, 2021
"ORHub aims for Q2, 2022 to bring total implant accountability to the medical device & surgical industry" IRVINE, CA / ACCESSWIRE / November 29, 2021 / ORHub, Inc. (OTC PINK:ORHB) has invested in...
From
ORHUB, Inc.
Via
AccessWire
Topics
Artificial Intelligence
ORHub Remains Capitalized & Focused On The Future
November 23, 2021
"ORHubTM has laid the foundation to support its new business design & forward strategy." IRVINE, CA / ACCESSWIRE / November 23, 2021 / ORHub, Inc. (OTC PINK:ORHB) provides a 2021 update and announces...
From
ORHUB, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Regulatory Compliance
< Previous
1
2
3
Next >
